Cite
HARVARD Citation
Barton, J. et al. (2017). Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab. Neurology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Barton, J. et al. (2017). Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab. Neurology. p. . [Online].